The challenge: Estimating the market size of innovative cancer Dx in Japan
A Japanese innovator company developing a breakthrough compound with potential applications in the cancer Dx, tissue adhesion prevention barriers, and scaffold materials for vascular grafts/transplantation spaces asked LucidQuest to support its efforts in better estimating the size of these market segments in Japan.
The Action: Primary and secondary research to define associated market sizes and GTM approaches.
LucidQuest conducted extensive primary and secondary research with key industry and competitor sources to estimate the relevant market sizes and the most efficient go-to-market approaches for our client.
The Result: Our insights contributed to the client’s GTM strategic decisions regarding market segment prioritization and next steps.
The output was a detailed report on potential market size, suggested GTM approaches, estimated 5-year growth and market dynamics, and likely emerging roadblocks for their asset.
Our client was able to use and combine our insights with their own market research to decide its next steps, including market segment prioritization.
#Oncology #CancerDx #CancerTreatment #GTMstrategy #StrategyOptimization #casestudy #ourwork